Canadian Stock Trader

Tag: TSX

  • Zacatecas Silver Closes the Second Tranche of Non-Brokered Private Placement

    VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (TSXV: ZAC | OTCQB: ZCTSF | FRA: 7TV) (“Zacatecas Silver” or the “Company”) is pleased to announce that it has closed the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news release dated July 14, 2026 and July 29, 2026) by issuing 14,639,941 Units at $0.07 per Unit for gross proceeds of $1,024,795.87. Under the entire Offering, the Company issued a total of 35,714,142 Units at $0.07 per Unit for gross proceeds of $2,499,989.94.

    Originally published via Source Article.

  • Zacatecas Silver Closes the Second Tranche of Non-Brokered Private Placement

    VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (TSXV: ZAC | OTCQB: ZCTSF | FRA: 7TV) (“Zacatecas Silver” or the “Company”) is pleased to announce that it has closed the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news release dated July 14, 2026 and July 29, 2026) by issuing 14,639,941 Units at $0.07 per Unit for gross proceeds of $1,024,795.87. Under the entire Offering, the Company issued a total of 35,714,142 Units at $0.07 per Unit for gross proceeds of $2,499,989.94.

    Originally published via Source Article.

  • Zacatecas Silver Closes the Second Tranche of Non-Brokered Private Placement

    VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (TSXV: ZAC | OTCQB: ZCTSF | FRA: 7TV) (“Zacatecas Silver” or the “Company”) is pleased to announce that it has closed the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Offering”, see news release dated July 14, 2026 and July 29, 2026) by issuing 14,639,941 Units at $0.07 per Unit for gross proceeds of $1,024,795.87. Under the entire Offering, the Company issued a total of 35,714,142 Units at $0.07 per Unit for gross proceeds of $2,499,989.94.

    Originally published via Source Article.

  • Sable Announces Grant of Options

    VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) — Sable Resources Ltd. (“Sable” or the “Company”) (TSXV:SAE | OTCQB:SBLRF) announces that the Company has granted an aggregate of 650,000 options to purchase common shares of the Company to directors, officers, employees and consultants in accordance with the Company’s stock option plan.  The options granted are exercisable at $0.55 for a period of five years.

    Originally published via Source Article.

  • Tree Island Steel Announces the Retirement of Nancy Davies and Appointment of a New Chief Operating Officer

    VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) — Tree Island Steel (”Tree Island” or the ”Company”) (TSX: TSL) announces the upcoming retirement of Chief Operating Officer, Nancy Davies, effective October 1, 2026. Following a planned succession process, the Company is pleased to announce the appointment of Brian Liu as Chief Operating Officer, effective the same day.

    Originally published via Source Article.

  • B2Gold Reports Fatality at the Masbate Gold Project

    VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) regrets to report that a fatality occurred at the Masbate Gold Project in the Philippines on Friday, August 28, 2026. The employee was performing scheduled maintenance at the Water Treatment Plant when a pipe burst, resulting in a fatal injury.

    Originally published via Source Article.

  • NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

    TORONTO and HAIFA, Israel, Aug. 28, 2026 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotechnology company developing exosome-based regenerative therapies, today announced that it is scheduled to participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, taking place September 9–10, 2026, in New York City.

    Originally published via Source Article.

  • Sustainable Innovation & Health Dividend Fund Normal Course Issuer Bid

    TORONTO, Aug. 28, 2026 (GLOBE NEWSWIRE) — Sustainable Innovation & Health Dividend Fund (the “Fund”) (TSX: SIH.UN) announced that it has filed a notice with the Toronto Stock Exchange (the “TSX”) and received its approval to make a normal course issuer bid (“NCIB”). Purchases pursuant to the NCIB will be made in the open market through the facilities of the TSX and Alternative Canadian Trading Systems. This NCIB will commence on September 3, 2026 and will terminate on September 2, 2027. In accordance with the Declaration of Trust by which the Fund is governed, market purchases pursuant to its NCIB may be effected by the Fund.

    Originally published via Source Article.

  • Sustainable Innovation & Health Dividend Fund Normal Course Issuer Bid

    TORONTO, Aug. 28, 2026 (GLOBE NEWSWIRE) — Sustainable Innovation & Health Dividend Fund (the “Fund”) (TSX: SIH.UN) announced that it has filed a notice with the Toronto Stock Exchange (the “TSX”) and received its approval to make a normal course issuer bid (“NCIB”). Purchases pursuant to the NCIB will be made in the open market through the facilities of the TSX and Alternative Canadian Trading Systems. This NCIB will commence on September 3, 2026 and will terminate on September 2, 2027. In accordance with the Declaration of Trust by which the Fund is governed, market purchases pursuant to its NCIB may be effected by the Fund.

    Originally published via Source Article.

  • Sustainable Innovation & Health Dividend Fund Normal Course Issuer Bid

    TORONTO, Aug. 28, 2026 (GLOBE NEWSWIRE) — Sustainable Innovation & Health Dividend Fund (the “Fund”) (TSX: SIH.UN) announced that it has filed a notice with the Toronto Stock Exchange (the “TSX”) and received its approval to make a normal course issuer bid (“NCIB”). Purchases pursuant to the NCIB will be made in the open market through the facilities of the TSX and Alternative Canadian Trading Systems. This NCIB will commence on September 3, 2026 and will terminate on September 2, 2027. In accordance with the Declaration of Trust by which the Fund is governed, market purchases pursuant to its NCIB may be effected by the Fund.

    Originally published via Source Article.